REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/29/2025
Back to search
Official data from USPTO
PAPITROL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
12/30/2025
Trademark type
Word
Nice classes
5
Filing date
06/21/2019
Registration date
12/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/29/2020
Last transaction
12/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
KR
Examiner
O'BRIEN,JENNIFER LYNN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genexine, Inc.
Representatives
Leigh Ann Lindquist Sughrue Mion, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; Pharmaceutical agents for treating asthmaPharmaceutical agents for the treatment of asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; Antibody fusion protein for medical treatment in the nature of pharmaceutical preparations for the treatment of HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; blood solventblood plasma; pharmaceutical preparations for the treatment of neutropenia
Publications
History of USPTO decisions and trademark events.
47 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/28/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/01/2021
FIMP
FINAL DISPOSITION PROCESSED
04/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2020
GPNX
NOTIFICATION PROCESSED BY IB
10/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2020
PUBO
PUBLISHED FOR OPPOSITION
10/13/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/30/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/10/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/10/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/10/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/10/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2020
ALIE
ASSIGNED TO LIE
08/21/2020
NREV
NOTICE OF REVIVAL - E-MAILED
08/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2020
PETG
PETITION TO REVIVE-GRANTED
08/04/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
08/04/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
06/05/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
06/04/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/28/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/25/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/25/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/25/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/25/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/25/2020
RFNT
REFUSAL PROCESSED BY IB
10/26/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/05/2019
RFRR
REFUSAL PROCESSED BY MPU
10/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2019
CNRT
NON-FINAL ACTION WRITTEN
09/19/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
09/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2019
CNRT
NON-FINAL ACTION WRITTEN
08/26/2019
DOCK
ASSIGNED TO EXAMINER
08/20/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2019
Continuous trademark protection
Get notified about every new filing that threatens PAPITROL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.